fb-pixel Skip to main content
Thermo Fisher’s share price rose more than 3.4 percent Thursday, closing at $494.38.

Thermo Fisher buys PPD for $17.4b in Waltham giant’s largest deal to date

Thermo Fisher’s share price rose more than 3.4 percent Thursday, closing at $494.38.

After a year of working from home at a card table, I’m paying the price at the physical therapist

Physical therapists say that although business plunged during the lockdown in the first half of 2020, they soon saw a surge of patients complaining about of head, neck, shoulder, and back pain linked to ergonomically unsound home office setups.

Federal panel recommends continued ‘pause’ on J&J vaccine. Doctors hope to reconvene in a week to 10 days

After a four-hour emergency meeting, the panel of independent experts who advise the Centers for Disease Control and Prevention said they needed more time to assess the potential risks of the shot, including whether it posed a danger to men and older people.

Tango Therapeutics to go public in $353 million SPAC deal

Tango launched out of Third Rock Ventures in 2017 and its cancer therapies are in the preclinical stage. With the SPAC merger, Tango plans to accelerate its lead candidate into the clinic in the fourth quarter of this year.

“Moderna will make as many updates to our COVID-19 vaccine as necessary until the pandemic is under control,” said CEO Stephane Bancel.
Data show Moderna’s vaccine continues to provide strong protection six months later
Moderna’s two-shot vaccine prevented more than 90 percent of COVID-19 cases and 95 percent of severe cases in updated trial data. The company also said it has begun testing two tweaked versions of its COVID-19 vaccine on mice in the hope the shots will act against a variant called B.1.351.

A Hologic mammogram machine.
Hologic to acquire European diagnostics company for $795 million
The Marlborough-based medical tech company has been growing through acquisitions. Already this year, Hologic has bought two other diagnostics firms for nearly $390 million combined.

Latest Headlines in Biotech

MIT professor and entrepreneur Sangeeta Bhatia.

MIT scientists launch Future Founders Initiative to help solve biotech’s ‘missing women’ problem

The Boston Biotech Working Group released a report that shows male faculty at MIT start companies at a higher rate than their female peers, and it outlines an action plan to close the gap.

Food and Drug Administration headquarters in White Oak, Md.

FDA has been giving a green light to Massachusetts biotechs

Five companies have won approvals from the agency in recent weeks.

Nurse Samantha Schuko prepares a dose of the Moderna vaccine at Gillette Stadium in Foxborough.

Moderna wants to add doses to its vials to speed COVID-19 vaccinations

As Moderna approaches its daily production benchmark of 1 million doses, the company’s president, Stephen Hoge, wants to increase the contents of each vial to 15 doses to relieve “one of the manufacturing bottlenecks.”

Moderna's COVID-19 vaccine is currently restricted to people at least 18 years old.

Moderna says vaccine study in adolescents has picked up speed

The Cambridge company hopes to have results by the summer.

On STATnews.com
The world is waiting for the results of Moderna’s vaccine trial.

Selling stock like clockwork, Moderna’s top doctor gets $1 million richer every week

As the world awaits results from Moderna’s pivotal COVID-19 vaccine study, Chief Medical Officer Tal Zaks has been selling his existing stock like clockwork, earning him over $50 million since the dawn of the pandemic.

CureVac's global headquarters is in Tuebingen, Germany.

Stock price of German COVID-19 vaccine maker with US headquarters in Boston closes up nearly 250% in its debut

'This is kind of beyond expectations,' says CureVac's chief financial officer.

The headquarters of biotech company CureVac in Tuebingen, Germany.

Another potential COVID-19 vaccine with Boston ties to enter clinical trials

CureVac, a German firm with about 20 employees here, says it has permission to start testing in people.

Nikitha Das, a scientist at Tango Therapeutics, gargled a salt solution at her home for later COVID-19 testing.coronavirus covid-19

For some biotech employees in the age of COVID-19, the workday starts at the bathroom sink

Tango Therapeutics in Cambridge tests workers' gargled samples, then e-mails the results later that day.